Higher Risk of Death With Endocrine Therapy Nonadherence

Women with early-stage hormone receptor–positive breast cancer who do not adhere or persist with adjuvant endocrine therapy have a higher risk of relapse or mortality, a new analysis suggests.
Medscape Medical News

source https://www.medscape.com/viewarticle/994272?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?